Ubs Group Ag Vaccinex, Inc. Transaction History

Ubs Group Ag

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.34 - $0.48 $5,519 - $7,792	-16,235 Reduced 99.39%	100 $0
Q1 2023 May 12, 2023	BUY	$0.39 - $0.65 $5,531 - $9,219	14,184 Added 659.41%	16,335 $6,000
Q4 2022 Feb 08, 2023	BUY	$0.44 - $0.74 $946 - $1,591	2,151 New	2,151 $1,000
Q1 2022 May 16, 2022	SELL	$0.92 - $1.94 $167 - $353	-182 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.04 - $2.12 $5,648 - $11,513	-5,431 Reduced 96.76%	182 $0

Q3 2021 Nov 15, 2021	BUY	$2.11 - $2.81 $3,949 - $5,260	1,872 Added 50.04%	5,613 $12,000
Q2 2021 Aug 13, 2021	SELL	$2.01 - $3.0 $50,183 - $74,901	-24,967 Reduced 86.97%	3,741 $10,000
Q1 2021 May 12, 2021	BUY	$2.09 - $5.11 $59,999 - $146,697	28,708 New	28,708 $86,000
Q3 2020 Nov 12, 2020	SELL	$1.75 - $8.19 $3,382 - $15,831	-1,933 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$3.28 - $4.24 $5,270 - $6,813	1,607 Added 492.94%	1,933 $7,000
Q1 2020 May 01, 2020	SELL	$3.96 - $8.37 $7,421 - $15,685	-1,874 Reduced 85.18%	326 $1,000
Q4 2019 Feb 14, 2020	SELL	$4.56 - $7.45 $683 - $1,117	-150 Reduced 6.38%	2,200 $11,000
Q3 2019 Nov 14, 2019	BUY	$4.02 - $7.93 $9,446 - $18,635	2,350 New	2,350 $17,000
Q2 2019 Aug 14, 2019	SELL	$4.89 - $8.11 $11,173 - $18,531	-2,285 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$3.67 - $5.5 $1,009 - $1,512	275 Added 13.68%	2,285 $12,000
Q4 2018 Feb 14, 2019	BUY	$3.64 - $7.12 $4,946 - $9,676	1,359 Added 208.76%	2,010 $7,000
Q3 2018 Nov 14, 2018	BUY	$6.95 - $11.64 $4,524 - $7,577	651 New	651 $5,000

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $287M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.